✦ LIBER ✦

Pre-trial evaluation of the potential for unblinding in drug trials: A prototype example

✍ Scribed by S.D. Walter; Shally Awasthi; L. Jeyaseelan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A method for the evaluation of complianc

✍ Erica Villa; Alberto Ferrari; Tiziana Barchi; Lorenza Rubbiani Gabriella Tabarro 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Inter-observer Variation in Outlining of

✍ S. Gwynne; E. Spezi; J. Staffurth; N. Palaniappan; L. Wills; C. Hurt; L. Nixon; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 58 KB

The challenge of conducting pharmacoecon

✍ Isabelle Chabot; Jacques LeLorier; Martin E. Blackstein 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Considering the case for an antidepressa

✍ Christopher F Dowrick; John G Hughes; Julia J Hiscock; Mark Wigglesworth; Thomas 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 275 KB

A randomised controlled trial evaluating

✍ Harmini Kaur Sidhu; John H. Price; Paul A. McCarron; Dermot F. McCafferty; A. Da 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

The Importance of Preclinical Trial Timi

✍ Qiongman Kong; Sarah Carothers; Yueming Chang; Chien-Liang Glenn Lin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB